Literature DB >> 10589907

Community-wide implementation of targeted testing for and treatment of latent tuberculosis infection.

C M Nolan1.   

Abstract

Treatment of latent infection due to Mycobacterium tuberculosis will likely increase in importance as a strategy to prevent tuberculosis in the United States. This review was undertaken to assess how targeted testing and treatment of latent tuberculosis infection are currently organized, with a focus on the extension of those services from public health clinics to other community sites. Targeted testing programs are now being implemented in primary care neighborhood clinics, syringe-exchange programs, jails, and teen health clinics. Organizational issues at those new sites include the need for a tracking system for clinical follow-up and for incentives to promote adherence. There is increasing experience with directly observed treatment of latent tuberculosis infection. Communities that receive large numbers of immigrants and refugees should prioritize the evaluation of those whose chest radiographs are suggestive of tuberculosis. Current studies continue to point out imperfections in the current tools, such as the tuberculin skin test and isoniazid. Finally, the advent of managed care, especially for Medicaid recipients, presents both opportunities and challenges for expansion of population-based preventive health services.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589907     DOI: 10.1086/520453

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Screening Latino adolescents for latent tuberculosis infection (LTBI).

Authors:  Carol Sipan; Elaine Blumberg; Melbourne Hovell; Norma Kelley; Kathleen Moser; Miguel Ocaña; Lawrence Friedman; Josephine Acosta; Alicia Vera; Marc Adams
Journal:  Public Health Rep       Date:  2003 Sep-Oct       Impact factor: 2.792

2.  Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.

Authors:  S M Arend; A C Engelhard; G Groot; K de Boer; P Andersen; T H Ottenhoff; J T van Dissel
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.

Authors:  D C Perlman; M N Gourevitch; C Trinh; N Salomon; L Horn; D C Des Jarlais
Journal:  J Urban Health       Date:  2001-09       Impact factor: 3.671

4.  Impact of immigration on the molecular epidemiology of tuberculosis in Rhode Island.

Authors:  Jessica Vanhomwegen; Awewura Kwara; Melissa Martin; Fizza S Gillani; Arnaud Fontanet; Peninnah Mutungi; Joyce Crellin; Stephen Obaro; Michael Gosciminski; E Jane Carter; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

5.  Interferon Gamma-Based Detection of Latent Tuberculosis Infection in the Border States of Nuevo Leon and Tamaulipas, Mexico.

Authors:  Eyal Oren; Gabriela Alatorre-Izaguirre; Javier Vargas-Villarreal; Maria Guadalupe Moreno-Treviño; Javier Garcialuna-Martinez; Francisco Gonzalez-Salazar
Journal:  Front Public Health       Date:  2015-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.